Sepracor Estorra (correction)
Executive Summary
Sepracor's pending insomnia agent Estorra (eszopiclone) is a single-isomer version of zopiclone (Sanofi-Aventis' Imovane). "The Pink Sheet" incorrectly reported Estorra's generic name (1"The Pink Sheet" Oct. 25, 2004, p. 33)...
You may also be interested in...
Pfizer/Neurocrine File First Indiplon NDA With Eye On Q4 2005 Launch
The first of two NDA filings for Pfizer/Neurocrine's insomnia agent indiplon puts the drug on track for a launch in the fourth quarter of 2005
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.